Vismodegib
| CAS No. | 879085-55-9 |
|---|---|
| MDL No. | MFCD12407408 |
| MF | C19H14Cl2N2O3S |
| MW | 421.30 |
| InChI Key | BPQMGSKTAYIVFO-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Vismodegib is a benzamide formed by the formal condensation of the carboxy group of 2-chloro-4-(methylsulfonyl)benzoic acid with the anilino group of 4-chloro-3-(pyridin-2-yl)aniline. It is used in the treatment of metastatic basal cell carcinoma. It functions as an antineoplastic agent, SMO receptor antagonist, Hedgehog signaling pathway inhibitor, and teratogenic agent. It is a sulfone, a member of benzamides, pyridines, and monochlorobenzenes.
| CAS No. | 879085-55-9 |
|---|---|
| Product Name | Vismodegib |
Biological Targets
SMO
Associated Conditions
pancreatic carcinoma·small cell lung carcinoma·gliosarcoma·basal cell carcinoma·triple-negative breast cancer·
* The information provided here is compiled from public sources and is for reference only.